维普中文期刊产品整合服务
49篇 您的检索式:作者名="RONCONI V"
    题名 作者 年代 出处 被引量
1Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment显示文摘Turchi F Ronconi V di Tizio V 2014Nutr Metab Cardiovasc Dis2014,24,5:1
2Aldosterone as a key mediator of the cardiometaholic syndrome in primary aldosteron- ism : an observational study 显示文摘Giacchetti G Ronconi V Turchi F 2007J Hypertens2007,25,1:1
3Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism:need for a standardized protocol显示文摘GIACCHETTI G RONCONI V LUCARELLI G 2006J Hypertens2006,24,:1
4Lower Bounding Schemes for Flow Shops with Blocking in-Process 显示文摘Ronconi D P Armentano V A 2001Journal of the Operational Research Society2001,52,2:1
5Aldosterone, mineralocor- tieoid receptor and the metabolic syndrome:role of the mineralocor- tieoid receptor antagonists 显示文摘Ronconi V Turchi F Appolloni G 2012Curr Vasc Pharmacol2012,10,2:1
6Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment显示文摘Turchi F Ronconi V di-Tizio V 2014Nutr Metab Cardiovasc Dis2014,24,5:1
7显示文摘Rossi G Boscaro M Ronconi V 2005Trends Endocrinol Metab2005,16,3:1
8Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism : need for a standardized protocol显示文摘Giacchetti G Ronconi V Lucarelli G 2006J Hypertens2006,24,4:1
9Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment 显示文摘Turchi F Ronconi V di Tizio V 2014Nutr Metab Cardiovasc2014,24,5:1
10Primary aldosteronism and essen- tial hypertension : assessment of cardiovascular risk at diagnosis and after treatment 显示文摘Turchi F Ronconi V di Tizio V 2014NutrMetab Cardiovasc2014,24,5:1
11Aldosterone as a cardio- vascular risk factor显示文摘Rossi G Boscaro M Ronconi V 2005Trends Endocrinol Metab2005,16,3:1
12Primary aldosteronism and essential hypertension:Assessment of cardiovascular risk at diag- nosis and after treatment显示文摘Turchi F Ronconi di Tizio V 2014Nutr Metab Cardiovasc Dis2014,24,5:1
13Small tumor size as favourable prognostic factor after adrenalectomy in Conn's adenoma显示文摘Giacchetti G Ronconi V Rilli S 2009Eur J Endocrinol2009,160,4:1
14A novel anticancer gold ( III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts 显示文摘Milacic V Chen D Ronconi L 2006Cancer Res2006,66,10:1
15Primary aldostemnism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment 显示文摘Turchi F Ronconi V di Tizio V 2014Nutr Metab Cardiovasc Dis2014,24,5:1
16Reduced nitric oxidelevels in acromegaly : cardiovascular implications 显示文摘Ronconi V Giacchetti G Mariniello B 2005BloodPress2005,14,4:1
17Aldosterone as a car- diovasoular risk factor显示文摘Rossi G Boscaro M Ronconi V 2005Trends Endocrinol Metab2005,16,3:1
18Aldostcrone as a cadiovascular risk factor显示文摘Rossi G Boscaro M Ronconi V 2005Trends in Endoerinology and Melaholism2005,16,:1
19Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism:need for a standardized protocol显示文摘GIACCHETTI G RONCONI V LUCARELLI G 2006J Hypertens2006,24,4:1
20Lower bounding schemes forflowshops with blocking irvprocess显示文摘Ronconi D P Armentano A V 2001European Journal ofOperational Research2001,52,11:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费